{
  "id": "7fcb5317993a30a8",
  "title": "STAT+: Pharmalittle: We\u2019re reading about worries over FDA voucher program, a new U.S. Novo exec, and more",
  "description": "FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall meeting",
  "content": "FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall meeting",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/04/novo-obesity-trump-psychedelics-fda-vouchers-switzerland/?utm_campaign=rss",
  "published_at": "2026-02-04T14:09:13+00:00",
  "fetched_at": "2026-02-05T00:29:17.336486+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "fda",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about worries over FDA voucher program, a new U.S. Novo exec, and more",
    "description": "FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall meeting",
    "url": "https://www.statnews.com/pharmalot/2026/02/04/novo-obesity-trump-psychedelics-fda-vouchers-switzerland/?utm_campaign=rss",
    "published": "2026-02-04T14:09:13+00:00",
    "source": "STAT"
  }
}